Immunai

Active#31 in Israel

AI immunology and drug discovery

Biotech›AI immunology and drug discovery

Founded2018

HQTel Aviv

RaisedUndisclosed total

Last roundSeries B · Nov 2021

Country of originIsraelListed in the Israel ranking

Where would you invest?HQ New York; R&D Tel AvivJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Israel · all sectors	Top 50	#31	Edition 0 – beta · October 2026	5 Oct 2026

Rank historyOct 2026 · #31First edition: no movements yet.

Estimated valuation

AI · Israel ranking

≈ USD 1.1bnUSD 560M–2.2bn · Unicorn Low confidence

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series B · USD 215M · Nov 2021
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

Undisclosed total raised in total

Date	Round	Amount	Type	Investors	Source
Nov 2021	Series B	USD 215M	Equity	—	timesofisrael.com

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Immunai as a PDF, on one of three angles only:

ValuationWhat is Immunai worth?

Versus competitorsIs #31 the right rank?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Invest

Back Immunai whether or not it has agreed: your intention joins the pool on Immunai, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back Immunai Or back biotech in Israel

Pool on ImmunaiBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Immunai?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round. Claiming never changes the rank.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Press & investor announcements1 source

Read by the AI at the next edition.

Comparable companies in Israel

Full Israel ranking →

Yotpo#30E-commerce software › retention marketingUnicorn Guardio#32Cybersecurity › consumer anti-scamUnicorn Kela#29Defence tech › battlefield operating systemUnicorn Lusha#33Martech › B2B sales intelligenceUnicorn

Sources. timesofisrael.com

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.